Thor Medical ASA

NEW
LTS:0R6Y (Norway)  
kr 2.3725 (0%) Apr 14
At Loss
P/B:
2.00
Market Cap:
kr 759.30M ($ 71.34M)
Enterprise V:
kr 637.22M ($ 59.87M)
Volume:
-
Avg Vol (2M):
22.18K
Trade In:
What is a stock summary page? Click here for an overview.
Volume:
-
At Loss
Avg Vol (2M):
22.18K

Business Description

Description
Thor Medical ASA is a Norway-based biopharmaceutical company. The Company is a producer and supplier of alpha-particle emitters for cancer therapy. The production process is based on separation of natural occurring radioactive decay products from thorium. The Company is utilizing alpha-emitters in radiotherapy and cancer treatments using Pb-212, which can be produced from naturally occurring isotope Thorium-232 and Lead-212. The Company has developed a proprietary technology for the manufacturing of radionuclides, alpha-particle emitters from natural resources. The high energy deposition and the short range of alpha particles make it possible to eradicate cancer cells while minimizing damage to nearby healthy cells.
Name Current Vs Industry Vs History
Cash-To-Debt 166.65
Equity-to-Asset 0.81
Debt-to-EBITDA -0.02
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 5.67
Quick Ratio 5.67
Cash Ratio 5.36

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -40.2
Shareholder Yield % -15.12

Profitability Rank

Name Current Vs Industry Vs History
ROE % -14.57
ROA % -11.88
ROIC % -15.04
3-Year ROIIC % 199.64
ROC (Joel Greenblatt) % -2942.53
ROCE % -12.35

Financials (Next Earnings Date:2025-08-29)

LTS:0R6Y's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016

Thor Medical ASA Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil kr)
EPS (TTM) (kr) -0.179
Beta 2.91
3-Year Sharpe Ratio 0.11
3-Year Sortino Ratio 0.25
Volatility % 202.81
14-Day RSI 51.03
14-Day ATR (kr) 0.076084
20-Day SMA (kr) 2.41825
12-1 Month Momentum % 83.68
52-Week Range (kr) 0.991089 - 3.389155
Shares Outstanding (Mil) 314.41

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Thor Medical ASA Filings

Filing Date Document Date Form
No Filing Data

Thor Medical ASA Stock Events

Financials Calendars
Event Date Price (kr)
No Event Data

Thor Medical ASA Frequently Asked Questions

What is Thor Medical ASA(LTS:0R6Y)'s stock price today?
The current price of LTS:0R6Y is kr2.37. The 52 week high of LTS:0R6Y is kr3.39 and 52 week low is kr0.99.
When is next earnings date of Thor Medical ASA(LTS:0R6Y)?
The next earnings date of Thor Medical ASA(LTS:0R6Y) is 2025-08-29.
Does Thor Medical ASA(LTS:0R6Y) pay dividends? If so, how much?
Thor Medical ASA(LTS:0R6Y) does not pay dividend.

Press Release

Subject Date
No Press Release